August: University of New England, ME. Gordon Research Conference on Membrane Transport Proteins. Section Chair. September: Panum Institute, University of Copenhagen, Copenhagen, and Denmark. “Obesity neuropsychiatric disorders: a brain AKTing badly”. September: Scandinavian conference on Molecular physiology of channels and transporters Sigtunastiftelsen, Stockholm. Key note speaker. dopamine transporter “SNAREing function”. November: Department of Pharmacology, UPenn, Philadelphia. and neuropsychiatric “Obesity disorders: a brain AKTing badly”. 2011: September: SB35 Transporter Meeting, Vienna, Austria. Plenary Lecture. “Syntaxin: teaching an old dog new tricks”. November: Department of Physiology and Biophysics, Case Western Reserve University. “How the Big GULP Cures the Fat Brain: Striatal Insulin Resistance and GLP-1 Signaling”. December: American College of Neuropsychopharmacology, Hilton Waikoloa Village, Hawaii. the Big GULP Cures the Fat Brain: Striatal Insulin Resistance and GLP-1 “How Signaling”. December: American College of Neuropsychopharmacology, Hilton Waikoloa Village, Hawaii. of the norepinephrine transporter sustains cortical hypodopaminergia and “Dysregulation schizophrenia-like behaviors in neuronal rictor null mice”. 2012: September: Lieber Institute for Brain Development, Baltimore. “Dopamine, Clean Up Your Insulin Signaling in “AKT”! Restoring Brain”. October: Sanford Burnham Medical Research Institute, Orlando. to Fat “How “AKT” Around with GLP-1”. Food: Just Say “NO” October: NIDA: Frontiers in Addiction Research, New Orleans. to Fat “How “AKT” Around with GLP-1”. Food: Just Say “NO” November: UMASS, Worcester. N-Terminus: Transport Function, “DAT “Levering Lipid Interactions and Neuropsychiatric Disorders”. March: of Monoamine Neurotransmission 5th CCHD Workshop, Vienna. “Metabolic imprinting in Obesity and Diabetes. March: Brain Institute, of Monoamine Neurotransmission in Vienna. “Metabolic imprinting Obesity and Diabetes.
August: University of New England, ME. Gordon Research Conference on Membrane Transport Proteins. Section Chair. September: Panum Institute, University of Copenhagen, Copenhagen, Denmark. “Obesity and neuropsychiatric disorders: a brain AKTing badly”. September: Scandinavian conference on Molecular physiology of channels and transporters Sigtunastiftelsen, Stockholm. Key note speaker. “SNAREing dopamine transporter function”. November: Department of Pharmacology, UPenn, Philadelphia. “Obesity and neuropsychiatric disorders: a brain AKTing badly”. 2011: September: SB35 Transporter Meeting, Vienna, Austria. Plenary Lecture. “Syntaxin: teaching an old dog new tricks”. November: Department of Physiology and Biophysics, Case Western Reserve University. “How the Big GULP Cures the Fat Brain: Striatal Insulin Resistance and GLP-1 Signaling”. December: American College of Neuropsychopharmacology, Hilton Waikoloa Village, Hawaii. “How the Big GULP Cures the Fat Brain: Striatal Insulin Resistance and GLP-1 Signaling”. December: American College of Neuropsychopharmacology, Hilton Waikoloa Village, Hawaii. “Dysregulation of the norepinephrine transporter sustains cortical hypodopaminergia and schizophrenia-like behaviors in neuronal rictor null mice”. 2012: September: Lieber Institute for Brain Development, Baltimore. “Dopamine, Clean Up Your “AKT”! Restoring Insulin Signaling in Brain”. October: Sanford Burnham Medical Research Institute, Orlando. “How to “AKT” Around Fat Food: Just Say “NO” with GLP-1”. October: NIDA: Frontiers in Addiction Research, New Orleans. “How to “AKT” Around Fat Food: Just Say “NO” with GLP-1”. November: UMASS, Worcester. “DAT N-Terminus: “Levering Transport Function, Lipid Interactions and Neuropsychiatric Disorders”. March: 5th CCHD Workshop, Vienna. “Metabolic imprinting of Monoamine Neurotransmission in Obesity and Diabetes. March: Brain Institute, Vienna. “Metabolic imprinting of Monoamine Neurotransmission in Obesity and Diabetes.